Non-Hodgkin Lymphoma — Year in Review Series on Relevant New Datasets and Advances
Jun 05, 2025•59 min•Season 25Ep. 28
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Summary
Drs. Stephen Ansell and Brian Hill review major treatment advances in non-Hodgkin lymphoma over the past year, focusing on diffuse large B-cell, mantle cell, and follicular lymphomas. The discussion covers new data on bispecific antibodies, antibody-drug conjugates, and CAR T-cell therapies, highlighting shifts in treatment paradigms, management of toxicities, and the role of MRD testing. They also explore emerging chemotherapy-free regimens and their impact on patient care.Episode description
Dr Stephen Ansell from Mayo Clinic in Rochester, Minnesota, and Dr Brian Hill from Cleveland Clinic Taussig Cancer Institute in Ohio summarize major treatment advances over the past year and review relevant ongoing clinical trials for patients with non-Hodgkin lymphoma.
CME information and select publications here.
For the best experience, listen in Metacast app for iOS or Android